| Component of cost |
|
Description |
| Provider cost |
|
|
| Recurrent costs |
|
emolument cost (salary, allowances and bonuses in year 2015) |
|
|
consumable cost (medical utilities and non-medical such as stationaries) |
|
|
utility cost (water, electricity and phone bill) |
|
|
maintenance cost (hospital building) |
|
|
training |
| Direct cost |
|
|
| Drug |
topical |
a) emollient; aquos cream, vaseline, ung emulsificant, aquous cream + vaseline, urea, liquid paraffin and others, b) steroid: hydrocortisone, clobetasone butyrate, mometasone, betamethasone valerate, clobetasol propionate and clobetasol shampoo, c) tar: liquor picis carbonis, sebitar shampoo, cerascalp, ung cocois, 20% coal tar bath, d) keratolytic agents: dithranol, salicylic acid, e) calcipotriol: daivonex, daivonet, xamiol, daivonex scalp solution, f) combination; diprosalic ointment, g) adjunctive therapy: antihistamine, oral antibiotic, topical antibiotic |
|
phototherapy |
narrowband UVB, oral PUVA, topical PUVA, bath PUVA |
|
systemic |
methotrexate, cyclosporine, acitretin , sulphasalazine |
|
biologic |
ustekinumab, infliximab, adalimumab , secukinumab and etanercept |
| Laboratory investigation |
|
LFT, FBS, FBC, RP, ANA, RF, ESR, CRP, Hepatitis B, Hepatitis C, HIV, Quantiferon gold, Mantoux |
| Procedural examination |
|
chest x-ray |
| Patient cost |
|
|
| Direct cost |
|
|
| Treatment |
|
treatments at private clinic/hospitals, traditional medicine, expenses on over the counter drugs, skin products and skin supplements |
| Indirect cost |
|
|
| Transportation |
|
transportation cost to hospital (to and fro) |
| Loss of productivity |
|
loss of income because of psoriasis |
